Tuesday, 15 April 2014

Glenmark Pharmaceuticals Ltd. through its Swiss Subsidiary receives USD 5 Mn. as milestone fee payment from Sanofi « New Drug Approvals

Glenmark Pharmaceuticals Ltd. through its Swiss Subsidiary receives USD 5 Mn. as milestone fee payment from Sanofi « New Drug Approvals:



'via Blog this'
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)